All Type of News
KRW 13 trillion pharmaceutical sales this year, expected to slightly increase
This year, pharmaceutical sales of domestic pharmaceutical companies are expected to narrowly decrease to KRW 12.8 trillion.
Gi-dal Bae and Ji-yong Lee, researchers at Shinhan Investment Corp., announced the above th...
Yuhan, Dong-A ST, Kwang Dong and Green Cross favored by foreignersIt was observed stocks of Yuhan Corporation, Dong-A ST, Kwang Dong Pharmaceutical and Green Cross, among domestic listed pharmaceutical companies, have been invested the most by...
|
Extended health insurance benefits for diseases, such as pancreatic cancer and leukemia
From the 1st of February, the health insurance benefits of treatments for various diseases, such as pancreatic cancer and leukemia, will be extended.
The Ministry of Health and Welfare(Minister Jin-yup Jung, hereinaf...
‘Yuhan and Dong-A’ interesting attention with antiviral API exportsYuhan and Dong-A were observed to secure firm competitiveness as having favorable conditions in antiviral API(active pharmaceutical ingredients) exports.
Yuhan Corporation is ...
|
‘Celebrex’ developed the most for bioequivalently approved generics last year
A pharmaceutical product which was developed as generics by the most number of pharmaceutical companies was ‘Celebrex’ last year.
According to the Medipana News’ analysis result of the Ministry of Food and Drug Safet...
Viagra’s design dispute, “Although Pfizer acquired justification…
Over the blue diamond-shape ‘Viagra’s’ design and trademark rights, Pfizer Pharmaceuticals and Hanmi Pharm have had complicated ties on lawsuits.
First of all, there is a trial for injunction against infringement of ...
‘Multinational pharmaceutical companies should change OTC drugs to be dealt directly by domestic companies’
While the pharmaceutical industry has various viewpoints over co-marketing of multinational pharmaceutical companies’ original products, the distribution industry has started to raise an argument that co-marketing of ...
Antibiotic prescriptions were decreased by 24%, annually 5.45%, for the past 6 years
The last year’s antibiotic prescriptions of domestic medical institutions were recorded at KRW 1.0077 trillion, decreased by 23.9%, KRW 316.4 billion, compared to the year of 2010, 6 years ago. Its average annual decr...
Almagel excluded to be used as reflux esophagitis treatment
Since the ‘reflux esophagitis’ indication of almagate drugs, including Almagel(Yuhan Corporation), has been excluded since the 17th of the last month, the relevant suspension market has been worried.
In order to fill...
ARB-type antihypertensives in the down-turning market
The Big 4 ARB-type antihypertensives – Twynsta(Boehringer Ingelheim), Amosartan(Hanmi Pharm), Exforge(Novartis) and Sevikar(Daiichi Sankyo) – have shown decreases altogether.
According to the UBIST data on the 28th, ...
